Prefilled Syringes Market Forecast 2022-2027: Industry Trends, Share, Size and Growth

The latest research study “Prefilled Syringes Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” by IMARC Group, finds that the global prefilled syringes market size reached US$ 6.31 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 10.94 Billion by 2027 exhibiting a growth rate (CAGR) of 9.20% during 2022-2027.

Request a free sample brochure:

Covid-19 Impact:

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Industry Definition and Application:

Prefilled syringes represent single-dose packets of injectable vaccines that are disposable in nature. In terms of designs and materials, they can be categorized into single-chamber, dual-chamber, customized, glass, and plastic variants. These prefilled syringes significantly lower the chances of drug contamination by avoiding the potential admixture-related contamination risks that can occur when syringes are inserted in a drug vial to draw out a dose. They further improve safety, enable convenient and quick delivery of drugs in the case of emergencies, and eliminate the on-site vial cleaning and depyrogenation procedures. As a result, prefilled syringes are being extensively utilized in hospitals and clinics across the globe.

Prefilled Syringes Market Trends and Drivers: 

The elevating usage of biologics and biosimilars to treat chronic ailments, such as diabetes, cancer, cardiovascular disorders, autoimmune diseases, etc., is primarily driving the prefilled syringes market. Additionally, the rising innovation in injectable delivery solutions and the introduction of technologically advanced self-injecting parenteral devices are acting as significant growth-inducing factors.

Besides this, the inflating investments undertaken by the government bodies to promote cutting-edge syringe production are also positively influencing the market growth. Furthermore, shifting preferences for home-based healthcare and the development of glass auto-injectors that prevent oxygen and water vapor from interacting with drugs and facilitate compatibility with varied filling machines are expected to propel the prefilled syringes market in the coming years.

Prefilled Syringes Market Report Scope
Report CoverageDetails
Market size value in 2021US$ 6.31 Billion
Market forecast in 2027US$ 10.94 Billion
Growth RateCAGR of 9.20% from 2022 to 2027
Base year for estimation2021
Historical data2016-2021
Forecast period2022-2027
Report coverageRevenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments coveredDesign, Material, Closing system, Application and End user.
Regional scopeNorth America, Europe, Asia-Pacific, Latin America, Middle East and Africa
Key companies profiledAbbott Laboratories, B. Braun Melsungen AG, Baxter International Inc., Bayer AG, Becton Dickinson and Company, Cardinal Health Inc., Catalent Inc., Fresenius SE & Co. KGaA, Gerresheimer AG, Nipro Corporation, Schott AG, Terumo Corporation and West Pharmaceutical Services Inc.
Market DynamicsParent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and future consumer dynamics, market condition analysis for forecast period,
Customization previewIf our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Report Segmentation:

The report has been segmented the market into following categories:

Breakup by Design:

  • Single-chamber Prefilled Syringes
  • Dual-chamber Prefilled Syringes
  • Customized Prefilled Syringes

Breakup by Material:

  • Glass Prefilled Syringes
  • Plastic Prefilled Syringes

Breakup by Closing System:

  • Staked Needle System
  • Luer Cone System
  • Luer Lock Form System

Breakup by Application:

  • Diabetes
  • Anaphylaxis
  • Rheumatoid Arthritis
  • Oncology
  • Others

Breakup by End User:

  • Hospitals
  • Clinics
  • Others

Click here to view detailed information with table of content:

By Geography:

  • North America (United States, Canada)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Others)
  • Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)

List of Major Key Players:

The major players in the market are Abbott Laboratories, B. Braun Melsungen AG, Baxter International Inc., Bayer AG, Becton Dickinson and Company, Cardinal Health Inc., Catalent Inc., Fresenius SE & Co. KGaA, Gerresheimer AG, Nipro Corporation, Schott AG, Terumo Corporation and West Pharmaceutical Services Inc.

 About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

By Michael Caine

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Posts